{
    "2021-01-06": [
        [
            {
                "time": "",
                "original_text": "沃森生物：推进H股发行提升关键领域优势",
                "features": {
                    "keywords": [
                        "沃森生物",
                        "H股发行",
                        "关键领域",
                        "优势"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "沃森生物：稳步推进港股上市 聚力强化优势业务",
                "features": {
                    "keywords": [
                        "沃森生物",
                        "港股上市",
                        "稳步推进",
                        "优势业务"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "沃森生物(300142.SZ)拟使用3亿元闲置募集资金用于暂时补充流动资金",
                "features": {
                    "keywords": [
                        "沃森生物",
                        "300142.SZ",
                        "闲置募集资金",
                        "补充流动资金"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "沃森生物(300142.SZ)：拟聘请安永为H股首发并在香港联交所主板上市的申报会计师",
                "features": {
                    "keywords": [
                        "沃森生物",
                        "300142.SZ",
                        "安永",
                        "H股首发",
                        "香港联交所"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}